Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxyd ecyl)-1,4-benzoquinone for the treatment of Primary Progressive Multiple Sclerosis

Details for Australian Patent Application No. 2009345604 (hide)

Owner The United States of America as represented by The Department of Health and Human Services Santhera Pharmaceuticals (Schweiz) AG

Inventors Meier, Thomas; Bielekova, Bibiana; McFarland, Henry F.

Agent Baldwins

Pub. Number AU-A-2009345604

PCT Pub. Number WO2010/124713

Priority 61/174,170 30.04.09 US; 09006030.2 30.04.09 EP

Filing date 18 December 2009

Wipo publication date 4 November 2010

International Classifications

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/124713 Priority application(s): WO2010/124713

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009345605-An adjustable shape changeable surgical implant system

2009345576-Input converter for an EEG monitoring system, signal conversion method and monitoring system